2005

1. Hirade K, Tanabe K, Niwa M, Ishisaki A, Nakajima K, Nakamura M, Sugiyama T, Katagiri Y, Kato K and Kozawa O.
Adenylyl cyclase-cAMP system inhibits thrombin-induced HSP27 in vascular smooth muscle cells.
J. Cell. Biochem. 2005;94:575-584.

2. Kanno Y, Ishisaki A, Yoshida M, Tokuda H, Numata O and Kozawa O.
SAPK/JNK plays a role in transforming growth factor-β-induced VEGF synthesis in osteoblasts.
Horm. Metab. Res. 2005;37:140-145.

3. Kanno Y, Ishisaki A, Yoshida M, Nakajima K, Tokuda H, Numata O and Kozawa O.
Adenylyl cyclase-cAMP system inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Mol. Cell. Endocrinol. 2005;229:75-82.

4. Matsuno H, Tokuda H, Ishisaki A, Shu E, Kitajima Y and Kozawa O.
P2Y12 receptors play a significant role on the development of platelet micro-aggregation in patients with diabetes.
J. Clin. Endocr. Metab. 2005;90:920-927.

5. Kumada M, Niwa M, Hara A, Matsuno H, Mori H, Ueshima S, Matsuo O, Yamamoto T and Kozawa O.
Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fiblinolytic cascade.
Invest. Ophth. Vis. Sci. 2005;46:1504-1507.

6. Yoshida M, Kanno Y, Ishisaki A, Tokuda H, Hirade K, Nakajima K, Katagiri Y, Shimizu K and Kozawa O.
Methotrexate suppresses inflammatory agonists-induced interleukin-6 synthesis in osteoblasts.
J. Rheumatology. 2005;32:787-795.

7. Yasuda E, Tokuda H, Ishisaki A, Hirade K, Kanno Y, Hanai Y, Nakamura N, Noda T, Katagiri Y and Kozawa O.
PPAR-γ ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/JNK activation in osteoblasts.
Biochem. Biophys. Res. Commun. 2005;328:137-143.

8. Nakajima K, Hirade K, Ishisaki A, Matsuno H, Suga H, Kanno Y, Shu E, Kitajima Y, Katagiri Y and Kozawa O.
Akt regulates thrombin-induced HSP27 phosphorylation in aortic smooth muscle cells:function at a point downstream from p38 MAP kinase.
Life Sci. 2005;77:96-107.

9. Tanabe K, Akamatsu S, Suga H, Takai S, Kato K, Dohi S and Kozawa O.
Midazolam suppresses thrombin-induced heat shock protein 27 phosphorylation through inhibition of p38 mitogen-activated protein kinase in cardiac myocytes.
J. Cell. Biochem. 2005;96:56-64.

10. Yoshida M, Tokuda H, Ishisaki A, Kanno Y, Harada A, Shimizu K and Kozawa O.
Tiludronate inhibits prostaglandin F2α-induced vascular endothelial growth factor synthesis in osteoblasts.
Mol. Cell. Endocrinol. 2005;236:59-66.

11. Noda T, Tokuda H, Yoshida M, Yasuda E, Hanai Y and Kozawa O.
Possible involvement of phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts.
Horm. Metab. Res. 2005;37:270-274.

12. Suga H, Nakajima K, Shu E, Kanno Y, Hirade K, Ishisaki A, Matsuno H, Tanabe K, Akamatsu S, Kato K, Oiso Y and Kozawa O.
Possible involvement of phosphatidylinositol 3-kinase/Akt signal pathway in vasopressin-induced HSP27 phosphorylation in aortic smooth muscle A10 cells.
Arch. Biochem. Biophys. 2005;438:137-145.

13. Shu E, Matsuno H, Akamatsu S, Kanno Y, Suga H, Nakajima K, Ishisaki A, Kato K, Kitajima Y and Kozawa O.
αB-crystallin is phosphorylated during myocardial infarction: involvement of platelet-derived growth factor-BB.
Arch. Biochem. Biophys. 2005;438:111-118.

14. Yasuda E, Kumada T, Takai S, Ishisaki A, Noda T, Matsushima-Nishiwaki R, Yoshimi N, Kato K, Toyoda H, Kaneoka Y, Yamaguchi A and Kozawa O.
Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma.
Biochem. Biophys. Res. Commun. 2005;337:337-342.